investordatabase.org

Genesys Capital

genesyscapital.com Direct investor

Genesys Capital is a life sciences venture capital firm that invests in and builds early-stage biotechnology, pharmaceutical, and medical technology companies. It has raised over $400 million across six early-stage venture funds and has invested in 44 companies.

Genesys Capital is a venture capital firm headquartered in Toronto, Canada, founded in 2000. It invests directly in companies, from seed to Series A, in biotechnology, pharmaceuticals, medical technology and life sciences. 44 portfolio companies, as it reports.

“We invest and build companies in the high growth sectors of biotechnology, pharmaceuticals and medical technology.”

— Genesys Capital, own website
Layer
Direct investor
Type
Venture capital
Stage
Seed – Series A
Headquarters
Toronto, Canada
Invests in
North America, Canada, USA
Sectors
biotechnology, pharmaceuticals, medical technology, life sciences
Founded
2000
Portfolio
44 companies

Team, as Genesys Capital publishes it

  • Stephanie Legere Associate
  • Jennifer Williams Partner and Chief Financial Officer
  • Damian Lamb Co-founder, Managing Director
  • Lisa Low Senior Vice President, Finance
  • Kelly Holman Co-founder, Managing Director
  • Sarah Farr Principal
  • Jamie Stiff Managing Director
  • Laurie Mak Associate
  • Christine Thoburn Office Manager

Names and roles exactly as listed on genesyscapital.com. Nothing else about these people is recorded.

Where this comes from

Every fact above was read from a page Genesys Capital publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.

Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.

Record 8538 · added 2026-09-29 · link last verified 2026-09-29 · confidence high

Similar investors

Listed under